Drug Profile
AJA 777
Alternative Names: AJA777Latest Information Update: 30 Jul 2015
Price :
$50
*
At a glance
- Originator Dr Falk Pharma
- Developer Ajinomoto
- Class Antispasmodics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Dyspepsia